A.Y. Finlay

34.4k total citations · 9 hit papers
273 papers, 22.5k citations indexed

About

A.Y. Finlay is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, A.Y. Finlay has authored 273 papers receiving a total of 22.5k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Dermatology, 79 papers in Immunology and 44 papers in Epidemiology. Recurrent topics in A.Y. Finlay's work include Dermatology and Skin Diseases (117 papers), Psoriasis: Treatment and Pathogenesis (73 papers) and Health Systems, Economic Evaluations, Quality of Life (40 papers). A.Y. Finlay is often cited by papers focused on Dermatology and Skin Diseases (117 papers), Psoriasis: Treatment and Pathogenesis (73 papers) and Health Systems, Economic Evaluations, Quality of Life (40 papers). A.Y. Finlay collaborates with scholars based in United Kingdom, Germany and Canada. A.Y. Finlay's co-authors include Ghazala Khan, Sam Salek, M.S. Lewis‐Jones, M.K.A. Basra, Richard Motley, Victoria Lewis, Calista Long, P.J. Dykes, Harald Gollnick and E C Coles and has published in prestigious journals such as The Lancet, Diabetes Care and Radiology.

In The Last Decade

A.Y. Finlay

259 papers receiving 21.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

1994 4.1k citations A.Y. Finlay et al. Clinical and Experimental Dermatology profile →
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..

1994 937 citations A.Y. Finlay et al. British Journal of Dermatology profile →
Psoriasis

2016 687 citations A.Y. Finlay et al. profile →
Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean?

2005 635 citations Sam Salek, A.Y. Finlay et al. profile →
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

2008 621 citations M.K.A. Basra, Sam Salek et al. British Journal of Dermatology profile →
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

2014 612 citations Florence Dalgard, F. Poot et al. profile →
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use

2010 605 citations A.Y. Finlay et al. British Journal of Dermatology profile →
Management of Acne

2003 593 citations A.Y. Finlay et al. Journal of the American Academy of Dermatology profile →
European evidence‐based (S3) guideline for the treatment of acne – update 2016 – short version

2016 228 citations A.Y. Finlay et al. Journal of the European Academy of Dermatology and Venereology profile →

Peers

A.Y. Finlay

DERMA

IMMUN

PHYSI

RHEUM

David J. Margolis United States

C. Paul France

Matthias Augustin Germany

Jacek C. Szepietowski Poland

P.C.M. van de Kerkhof Netherlands

L. Puig Spain

Alan B. Fleischer United States

Luigi Naldi Italy

Alice B. Gottlieb United States

Robert S. Stern United States

David J. Margolis United States

A.Y. Finlay

9.7k ×0.6

DERMA

6.8k ×1.0

IMMUN

4.1k ×0.9

2.8k ×1.0

PHYSI

2.9k ×1.2

RHEUM

Citations per year, relative to A.Y. Finlay A.Y. Finlay (= 1×) peers David J. Margolis

Countries citing papers authored by A.Y. Finlay

Since Specialization

Citations

This map shows the geographic impact of A.Y. Finlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.Y. Finlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.Y. Finlay more than expected).

Fields of papers citing papers by A.Y. Finlay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.Y. Finlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.Y. Finlay. The network helps show where A.Y. Finlay may publish in the future.

Co-authorship network of co-authors of A.Y. Finlay

This figure shows the co-authorship network connecting the top 25 collaborators of A.Y. Finlay. A scholar is included among the top collaborators of A.Y. Finlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.Y. Finlay. A.Y. Finlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salek, Sam, Faraz M Ali, Kennedy Otwombe, et al.. (2025). Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16). Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(2). 3120701962–3120701962.

Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2024). P047 Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review. British Journal of Dermatology. 191(Supplement_1). i36–i36.

Page, Melanie C., Leila Asfour, & A.Y. Finlay. (2024). Skin cancer decision-making in people with dementia. Clinical and Experimental Dermatology. 49(12). 1738–1739.

Finlay, A.Y., Faraz M Ali, Kennedy Otwombe, et al.. (2024). Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study. Diabetes Obesity and Metabolism. 27(2). 652–662. 1 indexed citations

Finlay, A.Y., Faraz M Ali, Harris Allen, et al.. (2024). Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study. European Journal Of Haematology. 113(1). 117–126. 4 indexed citations

Salek, Sam, A.Y. Finlay, Richard Kay, et al.. (2024). Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values. Quality of Life Research. 33(4). 1107–1119. 5 indexed citations

Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2024). The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology. 39(3). 631–679. 5 indexed citations

Krajewski, Piotr K., et al.. (2023). Translation and validation of the Polish language version of the Teenagers Quality of Life questionnaire (T-QoL). Advances in Dermatology and Allergology. 40(6). 753–756.

Finlay, A.Y., et al.. (2023). Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK. BMJ Open. 13(3). e066168–e066168. 8 indexed citations

10.

Ali, Faraz M, et al.. (2021). Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature. Health and Quality of Life Outcomes. 19(1). 194–194. 20 indexed citations

11.

Ali, Faraz M, et al.. (2021). Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open. 11(5). e047680–e047680. 72 indexed citations

12.

Chernyshov, Pavel V., Swen Malte John, L. Tomás-Aragonés, et al.. (2020). Quality of life measurement in occupational skin diseases. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Occupational Skin Disease. Journal of the European Academy of Dermatology and Venereology. 34(9). 1924–1931. 13 indexed citations

13.

Finlay, A.Y., Pavel V. Chernyshov, L. Tomás-Aragonés, et al.. (2020). Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. Journal of the European Academy of Dermatology and Venereology. 35(2). 318–328. 18 indexed citations

14.

Chernyshov, Pavel V., L. Tomás-Aragonés, Matthias Augustin, et al.. (2020). Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic. Journal of the European Academy of Dermatology and Venereology. 34(8). 1666–1671. 22 indexed citations

15.

Ali, Faraz M, et al.. (2016). A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis. British Journal of Dermatology. 176(3). 577–593. 46 indexed citations

16.

Finlay, A.Y., et al.. (2012). The Dermatology Life Quality Index (DLQI) and EuroQol-5D (EQ-5D): is there a correlation between these two measures? [Abstract]. ORCA Online Research @Cardiff (Cardiff University).

17.

Basra, M.K.A., et al.. (2012). The clinical and non-clinical factors influencing discharge decisions in dermatology: is there a need for discharge strategy? [Abstract]. International Journal of Clinical Pharmacy. 1 indexed citations

18.

Sowden, J. M., et al.. (2009). Dermatology outpatient case-mix survey for all Welsh Trusts, 2007. British Journal of Dermatology. 162(1). 152–158. 5 indexed citations

19.

Finlay, A.Y., et al.. (2003). Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a comparative study. Journal of the American Academy of Dermatology. 49(2). 249–254. 38 indexed citations

20.

Statham, B. N., A.Y. Finlay, & R. Marks. (1981). A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica. Acta Dermato Venereologica. 61(3). 270–271. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact